Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Runzao Zhiyang Capsule in Chronic Eczema
NCT02601222Phase 4Unknown
- Sponsor
- Sinopharm Tongjitang Pharmaceutical
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Runzao Zhiyang Capsule Arm with Placebo Arm (2 arms). Primary endpoint: Efficiency of disease at 4 weeks. Status: unknown.
02
Drugs
runzao zhiyang capsule
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02601222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02601222.